Goldman Sachs analysts are directing investor attention toward larger petrochemical companies, arguing that the recent Middle East conflict is triggering supply disturbances across global chemical markets both more rapidly and more intensely than earlier forecasts suggested.
The bank had previously set out a four-phase model for how the conflict might affect chemicals: first, energy-driven price increases; second, inventory restocking; third, margin compression; and finally, demand destruction. According to Goldman Sachs, the current cost shock is accelerating through these stages and in some instances is compressing or bypassing them entirely.
Goldman Sachs singles out Asia as a region where the signal of disruption is arriving most quickly. The firm notes that downstream sectors such as textiles and packaging are among the earliest to show material impacts from the unfolding cost shock.
Beyond headline price moves, the bank says investor attention should shift to dynamics around inventory stocking, consumer affordability, and the early indicators of demand destruction. Those factors, Goldman Sachs adds, could determine how long and how broadly the shock reverberates across supply chains.
Against that backdrop, Goldman Sachs recommends concentrating on larger-cap petrochemical names. The rationale is that greater scale, more flexible balance sheets, and more advanced global procurement operations should better absorb the working capital volatility and procurement disruptions that the bank anticipates.
The firm identifies three top stocks that meet these criteria:
- Air Liquide - Goldman Sachs keeps a Buy rating on the industrial gases company with a price target of 180.52. The bank believes Air Liquides scale and financial strength make it well positioned to navigate the current market volatility tied to Middle East supply disruptions.
- BASF (ETR:BASFN) - Goldman Sachs assigns a Buy rating and a price target of 50.94 to BASF SE. The bank points to the companys larger capitalization and operational flexibility as advantages during this period of supply-chain uncertainty and working capital pressure.
- Novonesis - Goldman Sachs rates Novonesis as a Buy with a price target of Dkr387.30. The recommendation rests on the companys balance-sheet strength and global procurement capabilities, which the bank believes will help it manage the accelerating cost shock impacting the sector.
Goldman Sachs emphasizes that, as the supply shock transmits more quickly through the chemical value chain, investors should weigh firm-specific attributes such as financial flexibility and procurement sophistication when making portfolio decisions.
For market participants assessing exposure to the petrochemical complex, Goldman Sachs' guidance highlights a preference for companies that can deploy scale and financial resources to blunt short-term volatility while maintaining operational continuity across disrupted supply networks.